Eagle Ridge Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.12M Buy
1,450
+156
+12% +$129K 0.1% 64
2024
Q3
$1.15M Buy
1,294
+1
+0.1% +$899 0.1% 61
2024
Q2
$1.17M Sell
1,293
-212
-14% -$170K 0.11% 65
2024
Q1
$1.17M Sell
1,505
-13
-0.9% -$9.25K 0.11% 66
2023
Q4
$885K Hold
1,518
0.09% 80
2023
Q3
$815K Sell
1,518
-247
-14% -$127K 0.09% 75
2023
Q2
$828K Sell
1,765
-150
-8% -$62.9K 0.09% 83
2023
Q1
$658K Hold
1,915
0.07% 88
2022
Q4
$701K Hold
1,915
0.08% 88
2022
Q3
$619K Buy
1,915
+300
+19% +$95K 0.08% 88
2022
Q2
$524K Sell
1,615
-100
-6% -$30K 0.06% 95
2022
Q1
$491K Sell
1,715
-72
-4% -$18.5K 0.05% 107
2021
Q4
$494K Hold
1,787
0.05% 111
2021
Q3
$413K Buy
1,787
+72
+4% +$17.8K 0.05% 108
2021
Q2
$394K Hold
1,715
0.05% 105
2021
Q1
$320K Hold
1,715
0.04% 109
2020
Q4
$290K Sell
1,715
-100
-6% -$14.9K 0.04% 117
2020
Q3
$269K Buy
+1,815
New +$281K 0.04% 127

Other funds holding LLY

Eagle Ridge Investment Management's LLY Position: Q4 2024 in Review

Eagle Ridge Investment Management increased its Eli Lilly (LLY) stake by 12% in Q4 2024, buying an estimated $129K and bringing the position to 1,450 shares worth $1.12M. The position accounts for 0.1% of the portfolio, ranked #64.

Eagle Ridge Investment Management first reported a position in LLY in Q3 2020 and has held it in 18 quarters since. The position peaked at $1.17M in Q1 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Eagle Ridge Investment Management held 1,450 shares of Eli Lilly worth $1.12M as of Q4 2024.
  • Eagle Ridge Investment Management bought 156 Eli Lilly shares in Q4 2024, an estimated $129K.
  • Eli Lilly made up 0.1% of Eagle Ridge Investment Management's portfolio in Q4 2024, its #64 holding.
  • Eagle Ridge Investment Management first reported a position in Eli Lilly in Q3 2020 and has held it in 18 quarters since.
  • Eagle Ridge Investment Management's Eli Lilly position peaked at $1.17M in Q1 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Eagle Ridge Investment Management's 13F filing for Q4 2024, filed 27 Jan 2025.